EndometriosisNCT07087756
The Effect of Temporary Ovarian Suspension to the Abdominal Wall During Laparoscopic Endometriosis Surgery for Adhesion Prevention -A Comparative and Prospective Study
A study testing laparoscopic ovarian suspension in people with Endometriosis and Abdominal Adhesions, run by Carmel Medical Center at 1 site in Israel.
Trial summary
Pelvic adhesions, particularly between ovaries and pelvic sidewall, frequently complicate endometriosis surgery. Despite various interventions, no widely accepted solution exists. Small studies suggest temporary ovarian suspension may reduce adhesion formation. Read more about this study
- Who is it for?
- Ages 18 to 50 years, women only
- Conditions the study is for
- Endometriosis, Abdominal Adhesions
- What is being tested?
- laparoscopic ovarian suspension
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 76 participants
- Where
- 1 siteIsrael
- Study dates
- 16 Mar 2025to Jul 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Patients with moderate to severe endometriosis with suspected adhesions, lesions in the ovary, ovarian fossa, utero-sacral ligaments, pouch of douglas, or involvement of the intestine as seen in preoperative assessment who are willing to participate in the study including postoperative follow-up assessments.
Who cannot join
- Patients who are not intended to have an endometriosis operation. Patients with minimal to mild endometriosis and no suspected adhesions or ovarian, ovarian fossa, utero-sacral ligament, pouch of douglas involvement on preoperative assessment.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Israel1 site, 1 recruiting
- Recruiting
Carmel Medical Center
Haifa, 34362
Yuval Kaufman, MD, +97248250336, mdykaufman@gmail.com
About this study
Official title: The Effect of Temporary Ovarian Suspension to the Anterior Abdominal Wall During Laparoscopic Endometriosis Surgery for Adhesion Prevention -A Comparative and Prospective Study
Pelvic adhesions, particularly between ovaries and pelvic sidewall, frequently complicate endometriosis surgery. Despite various interventions, no widely accepted solution exists. Small studies suggest temporary ovarian suspension may reduce adhesion formation. This technique, which temporarily elevates ovaries postoperatively, shows promise but requires further investigation to confirm its efficacy and long-term outcomes.
This prospective, single-blinded, randomized controlled study compares adhesion formation in endometriosis patients at risk for ovarian adhesions. Participants are randomized to undergo laparoscopic surgery with temporary ovarian suspension or standard care without ovarian suspension. Pain and suture removal eagerness are assessed via daily questionnaires. Blinded ultrasound experts evaluate adhesions at 6 and 13 weeks postoperatively. No anti-adhesive barriers are used to minimize confounding factors
Read the detailed description
Endometriosis is a chronic condition characterized by growth of endometrial tissue in sites other than the uterine cavity, most commonly in the pelvic cavity, including the ovaries, the uterosacral ligaments, and the pouch of Douglas. Laparoscopic excision of endometriosis lesions has become the gold standard treatment. At follow-up, relief of pain and quality of life after endometriosis surgical treatment ranges between 50% and 95%. However, pelvic surgery for endometriosis has been associated with a high rate of postoperative adhesion formation. The incidence of pelvic adhesions at second-look laparoscopy in the initial few weeks after surgery has been reported to be between 50% and 100%. The ovaries are the most common site involved by adhesions because of their anatomic localization (close to the pelvic sidewall and the homolateral tube) and the fragility of the coelomic epithelium that covers the ovarian surface [7,8]. In addition, when the posterior pelvic compartment is involved, obliteration of the pouch of Douglas is often observed as a result of a post-inflammatory process causing ovarian adhesions [9]. Women with higher risk for postoperative ovarian adhesions include those who have preoperative ovarian adhesions or patients undergoing ovarian cystectomy, peritonectomy of the ovarian fossa or extensive pelvic adhesiolysis. Postoperative retained free fluid with blood and postoperative infections may also increase the risk for adhesions. Postoperative adhesions are a source of major concern because of their potential consequences including persistent pelvic pain, dyspareunia (difficult or painful sexual intercourse), infertility, intestinal obstruction, and complications at subsequent surgery.
A wide range of interventions has been tried in the past in order to reduce postoperative pelvic adhesions. This includes intra-peritoneal administration of anti-adhesive solutions such as icodextrin and hyaluronic acid. Various drugs including steroids and heparin have also been tried in the past but none of them have gained wide acceptance (Metwally et al., 2006; Kamel, 2010). Oxidized regenerated cellulose was found to reduce postoperative adhesion in two very small RCTs (Ahmad et al., 2008).
Intra-operative suspension of the ovaries to the anterior abdominal wall is sometimes used to facilitate ovarian retraction and improve exposure of the pelvis during surgery for severe endometriosis (Cutner et al., 2004). Temporary ovarian suspension can be achieved using a straight needle and absorbable suture to suspend the ovary to the abdominal wall with an external knot tie that can be easily removed at any time after surgery. Two small observational studies suggested that temporary ovarian suspension for 4-7 days following surgery for severe endometriosis may reduce the frequency of postoperative pelvic adhesions (Abuzeid et al., 2002; Ouahba et al., 2004).
The Objective of the Study The primary objective of the study is to examine adhesion formation following laparoscopic surgery with temporary ovarian suspension removed a week after surgery.
The secondary objective is the analyze patient symptoms and adherence to the ovarian suspension as well as request to remove the suture before one week post operative.
Rationale for conducting the study If ovarian suspension is indeed beneficial it can be incorporated as part of common practice for laparoscopic endometriosis surgery.
Methods This is a prospective single-blinded randomized controlled interventional study.
Patients scheduled for laparoscopic surgery due to endometriosis with suspected adnexal adhesions, lesions of the ovary, ovarian fossa, uterosacral ligaments, pouch of Douglas, or involvement of the bowel, as seen by imaging, will be included. A comparison will be made between suspended ovaries in the study group vs. non-suspended ovaries in the control group. During surgery, the primary surgeon will inspect the pelvis. If on the side of the relevant ovary there are adhesions and/or ovarian cyst and/or peritoneal lesions around the ovarian fossa and uterosacral ligament, an ovarian suspension will be performed according to randomization. The randomization process will be based on a preformed list produced by the statistician which will be used during surgery. In case of bilateral pelvic involvement, the left ovary will be the first to be acted on according to the randomization result (i.e suspend/not suspend). In case of ovarian cysts, the surgeon will decide upon treatment method of the cyst during surgery. Suspension of the ovary will be performed using Monocryl absorbable suture. In order to reduce confounding variables, there will be no use of anti-adhesive barriers. Removal of the suspension will be performed at the clinic a week after surgery unless the patient requests to remove the suture earlier. Patients will be asked to fill a daily questionnaire describing the amount of pain according to VAS score they are experiencing due to ovarian suspension and how eager they are to remove the suture prematurely on a scale of 1-10.
Preoperative and postoperative ultrasound evaluation will be performed by one of two dedicated ultrasound experts using a Voluson E10 ultrasound. During postoperative evaluation, the experts will be blinded as to whether ovarian suspension was performed or not. Postoperative ultrasound will be performed 6 and 13 weeks following surgery and will include description of the size of the ovary, location and severity of adhesions.
Statistical analysis will be performed according to each suspended vs non-suspended ovary, i.e. the number of ovaries suspended for the study group vs, the number of non-suspended ovaries in the control group patients.
- Conditions
- Endometriosis, Abdominal Adhesions
- Being tested
- laparoscopic ovarian suspension
- Keywords
- endometriosis, ovarian suspension, laparoscopy, abdominal adhesions
- Medical subject headings
- Endometriosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
laparoscopic ovarian suspensionProcedure or surgery
Suspension of the ovary during laparoscopy for endometriosis
| Study group | Role | What they receive |
|---|---|---|
| Suspended Ovary | Active comparator | Ovary suspended during laparoscopy for endometriosis surgery Receives: Procedure: laparoscopic ovarian suspension |
| Non-suspended ovary | Sham comparator | Ovaries not suspended during laparoscopy for endometriosis Receives: Procedure: laparoscopic ovarian suspension |
What is being measured
The primary outcome is the main question the study is designed to answer.
Adhesion formation following laparoscopic surgery with temporary ovarian suspension as assessed in post-operative ultrasound visits at weeks 6,13 following surgery
The primary objective of the study is to examine adhesion formation following laparoscopic surgery with temporary ovarian suspension removed a week after surgery. Assessment of adhesions will be performed by ultrasound before surgery and then at 6 week and 13-week post-surgery. Assessment will be performed by an ultrasound specialist who is blinded to the surgical procedure. Adhesions are marked as negative or positive per organ including left and right ovary, left and right tube and other locations (rectosigmoid, uterus, bladder, pouch of Douglas).
Measured: From enrollment to last follow-up visit at 13 weeks post surgery
Secondary outcomes (2)
Patient pain during the first week following laparoscopy
The secondary objective is to analyze patient pain symptoms during the first week after surgery. Patients will report pain symptoms daily, as measured by Visual Analog Score for pain on a scale of 0-10.
Measured: From enrollment to 1 week post-operative follow-up visit
Patient tolerability to ovarian suspension during the first week following surgery
Patient will report daily on their eagerness to remove the suture temporarily suspending each ovary to the abdominal wall on a scale from 0 to 10 during the first week after surgery.
Measured: From enrollment to 1 week post-operative follow-up visit
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jul 2025
- Study start16 Mar 2025
- Primary completionMar 2027 (estimated)
- Study completionJul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (10)Papers the sponsor has linked to this study.
- Other trials for EndometriosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 76 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Carmel Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yuval Kaufman, Carmel Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07087756
- Sponsor's protocol ID
- CMC-0110-24
- Status last verified
- Jul 2025
- First submitted
- 26 Jun 2025
- Last updated
- 28 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Patients outcomes
Publications
Davey AK, Maher PJ. Surgical adhesions: a timely update, a great challenge for the future. J Minim Invasive Gynecol. 2007 Jan-Feb;14(1):15-22. doi: 10.1016/j.jmig.2006.07.013.
PubMed 17218224Hudelist G, Fritzer N, Staettner S, Tammaa A, Tinelli A, Sparic R, Keckstein J. Uterine sliding sign: a simple sonographic predictor for presence of deep infiltrating endometriosis of the rectum. Ultrasound Obstet Gynecol. 2013 Jun;41(6):692-5. doi: 10.1002/uog.12431.
PubMed 23400893diZerega GS, Campeau JD. Peritoneal repair and post-surgical adhesion formation. Hum Reprod Update. 2001 Nov-Dec;7(6):547-55. doi: 10.1093/humupd/7.6.547.
PubMed 11727863Kavic SM, Kavic SM. Adhesions and adhesiolysis: the role of laparoscopy. JSLS. 2002 Apr-Jun;6(2):99-109.
PubMed 12113430diZerega GS. Contemporary adhesion prevention. Fertil Steril. 1994 Feb;61(2):219-35. doi: 10.1016/s0015-0282(16)56507-8.
PubMed 8299773Mabrouk M, Montanari G, Guerrini M, Villa G, Solfrini S, Vicenzi C, Mignemi G, Zannoni L, Frasca C, Di Donato N, Facchini C, Del Forno S, Geraci E, Ferrini G, Raimondo D, Alvisi S, Seracchioli R. Does laparoscopic management of deep infiltrating endometriosis improve quality of life? A prospective study. Health Qual Life Outcomes. 2011 Nov 6;9:98. doi: 10.1186/1477-7525-9-98.
PubMed 22054310Ouahba J, Madelenat P, Poncelet C. Transient abdominal ovariopexy for adhesion prevention in patients who underwent surgery for severe pelvic endometriosis. Fertil Steril. 2004 Nov;82(5):1407-11. doi: 10.1016/j.fertnstert.2004.03.060.
PubMed 15533368Garry R, Clayton R, Hawe J. The effect of endometriosis and its radical laparoscopic excision on quality of life indicators. BJOG. 2000 Jan;107(1):44-54. doi: 10.1111/j.1471-0528.2000.tb11578.x.
PubMed 10645861Garry R. Laparoscopic excision of endometriosis: the treatment of choice? Br J Obstet Gynaecol. 1997 May;104(5):513-5. doi: 10.1111/j.1471-0528.1997.tb11523.x. No abstract available.
PubMed 9166188Farquhar C. Endometriosis. BMJ. 2007 Feb 3;334(7587):249-53. doi: 10.1136/bmj.39073.736829.BE. No abstract available.
PubMed 17272567
Study at a glance
From the registry record, last updated by the sponsor on 28 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Temporary Ovarian Suspension to the Anterior Abdominal Wall During Laparoscopic Endometriosis Surgery for Adhesion Prevention -A Comparative and Prospective Study
- ClinicalTrials.gov ID
- NCT07087756
- Acronym / sponsor ID
- CMC-0110-24
- Conditions
- Endometriosis, Abdominal Adhesions
- Keywords
- endometriosis, ovarian suspension, laparoscopy, abdominal adhesions
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 76 participants (estimated)
- Lead sponsor
- Carmel Medical CenterUniversity, hospital or other
- Study start
- 16 Mar 2025 (actual)
- Primary completion
- Mar 2027 (estimated)
- Study completion
- Jul 2027 (estimated)
- First posted
- 28 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pelvic adhesions, particularly between ovaries and pelvic sidewall, frequently complicate endometriosis surgery. Despite various interventions, no widely accepted solution exists. Small studies suggest temporary ovarian suspension may reduce adhesion formation. This technique, which temporarily elevates ovaries postoperatively, shows promise but requires further investigation to confirm its efficacy and long-term outcomes.
This prospective, single-blinded, randomized controlled study compares adhesion formation in endometriosis patients at risk for ovarian adhesions. Participants are randomized to undergo laparoscopic surgery with temporary ovarian suspension or standard care without ovarian suspension. Pain and suture removal eagerness are assessed via daily questionnaires. Blinded ultrasound experts evaluate adhesions at 6 and 13 weeks postoperatively. No anti-adhesive barriers are used to minimize confounding factors
Detailed description
Endometriosis is a chronic condition characterized by growth of endometrial tissue in sites other than the uterine cavity, most commonly in the pelvic cavity, including the ovaries, the uterosacral ligaments, and the pouch of Douglas. Laparoscopic excision of endometriosis lesions has become the gold standard treatment. At follow-up, relief of pain and quality of life after endometriosis surgical treatment ranges between 50% and 95%. However, pelvic surgery for endometriosis has been associated with a high rate of postoperative adhesion formation. The incidence of pelvic adhesions at second-look laparoscopy in the initial few weeks after surgery has been reported to be between 50% and 100%. The ovaries are the most common site involved by adhesions because of their anatomic localization (close to the pelvic sidewall and the homolateral tube) and the fragility of the coelomic epithelium that covers the ovarian surface [7,8]. In addition, when the posterior pelvic compartment is involved, obliteration of the pouch of Douglas is often observed as a result of a post-inflammatory process causing ovarian adhesions [9]. Women with higher risk for postoperative ovarian adhesions include those who have preoperative ovarian adhesions or patients undergoing ovarian cystectomy, peritonectomy of the ovarian fossa or extensive pelvic adhesiolysis. Postoperative retained free fluid with blood and postoperative infections may also increase the risk for adhesions. Postoperative adhesions are a source of major concern because of their potential consequences including persistent pelvic pain, dyspareunia (difficult or painful sexual intercourse), infertility, intestinal obstruction, and complications at subsequent surgery.
A wide range of interventions has been tried in the past in order to reduce postoperative pelvic adhesions. This includes intra-peritoneal administration of anti-adhesive solutions such as icodextrin and hyaluronic acid. Various drugs including steroids and heparin have also been tried in the past but none of them have gained wide acceptance (Metwally et al., 2006; Kamel, 2010). Oxidized regenerated cellulose was found to reduce postoperative adhesion in two very small RCTs (Ahmad et al., 2008).
Intra-operative suspension of the ovaries to the anterior abdominal wall is sometimes used to facilitate ovarian retraction and improve exposure of the pelvis during surgery for severe endometriosis (Cutner et al., 2004). Temporary ovarian suspension can be achieved using a straight needle and absorbable suture to suspend the ovary to the abdominal wall with an external knot tie that can be easily removed at any time after surgery. Two small observational studies suggested that temporary ovarian suspension for 4-7 days following surgery for severe endometriosis may reduce the frequency of postoperative pelvic adhesions (Abuzeid et al., 2002; Ouahba et al., 2004).
The Objective of the Study The primary objective of the study is to examine adhesion formation following laparoscopic surgery with temporary ovarian suspension removed a week after surgery.
The secondary objective is the analyze patient symptoms and adherence to the ovarian suspension as well as request to remove the suture before one week post operative.
Rationale for conducting the study If ovarian suspension is indeed beneficial it can be incorporated as part of common practice for laparoscopic endometriosis surgery.
Methods This is a prospective single-blinded randomized controlled interventional study.
Patients scheduled for laparoscopic surgery due to endometriosis with suspected adnexal adhesions, lesions of the ovary, ovarian fossa, uterosacral ligaments, pouch of Douglas, or involvement of the bowel, as seen by imaging, will be included. A comparison will be made between suspended ovaries in the study group vs. non-suspended ovaries in the control group. During surgery, the primary surgeon will inspect the pelvis. If on the side of the relevant ovary there are adhesions and/or ovarian cyst and/or peritoneal lesions around the ovarian fossa and uterosacral ligament, an ovarian suspension will be performed according to randomization. The randomization process will be based on a preformed list produced by the statistician which will be used during surgery. In case of bilateral pelvic involvement, the left ovary will be the first to be acted on according to the randomization result (i.e suspend/not suspend). In case of ovarian cysts, the surgeon will decide upon treatment method of the cyst during surgery. Suspension of the ovary will be performed using Monocryl absorbable suture. In order to reduce confounding variables, there will be no use of anti-adhesive barriers. Removal of the suspension will be performed at the clinic a week after surgery unless the patient requests to remove the suture earlier. Patients will be asked to fill a daily questionnaire describing the amount of pain according to VAS score they are experiencing due to ovarian suspension and how eager they are to remove the suture prematurely on a scale of 1-10.
Preoperative and postoperative ultrasound evaluation will be performed by one of two dedicated ultrasound experts using a Voluson E10 ultrasound. During postoperative evaluation, the experts will be blinded as to whether ovarian suspension was performed or not. Postoperative ultrasound will be performed 6 and 13 weeks following surgery and will include description of the size of the ovary, location and severity of adhesions.
Statistical analysis will be performed according to each suspended vs non-suspended ovary, i.e. the number of ovaries suspended for the study group vs, the number of non-suspended ovaries in the control group patients.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Suspended Ovary | Active comparator | Procedure: laparoscopic ovarian suspensionOvary suspended during laparoscopy for endometriosis surgery |
| Non-suspended ovary | Sham comparator | Procedure: laparoscopic ovarian suspensionOvaries not suspended during laparoscopy for endometriosis |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Patients with moderate to severe endometriosis with suspected adhesions, lesions in the ovary, ovarian fossa, utero-sacral ligaments, pouch of douglas, or involvement of the intestine as seen in preoperative assessment who are willing to participate in the study including postoperative follow-up assessments.
Key exclusion criteria (1 listed)
- Patients who are not intended to have an endometriosis operation. Patients with minimal to mild endometriosis and no suspected adhesions or ovarian, ovarian fossa, utero-sacral ligament, pouch of douglas involvement on preoperative assessment.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| laparoscopic ovarian suspensionSuspension of the ovary during laparoscopy for endometriosis | Procedure or surgery | Non-suspended ovary, Suspended Ovary |
Primary outcome
Adhesion formation following laparoscopic surgery with temporary ovarian suspension as assessed in post-operative ultrasound visits at weeks 6,13 following surgery
Time frame: From enrollment to last follow-up visit at 13 weeks post surgery
The primary objective of the study is to examine adhesion formation following laparoscopic surgery with temporary ovarian suspension removed a week after surgery. Assessment of adhesions will be performed by ultrasound before surgery and then at 6 week and 13-week post-surgery. Assessment will be performed by an ultrasound specialist who is blinded to the surgical procedure. Adhesions are marked as negative or positive per organ including left and right ovary, left and right tube and other locations (rectosigmoid, uterus, bladder, pouch of Douglas).
2 secondary outcomes
Patient pain during the first week following laparoscopy
Time frame: From enrollment to 1 week post-operative follow-up visit
Patient tolerability to ovarian suspension during the first week following surgery
Time frame: From enrollment to 1 week post-operative follow-up visit
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jul 2025.
- Results publication: PubMed 17218224Davey AK, Maher PJ. Surgical adhesions: a timely update, a great challenge for the future. J Minim Invasive Gynecol. 2007 Jan-Feb;14(1):15-22. doi: 10.1016/j.jmig.2006.07.013.
- Results publication: PubMed 23400893Hudelist G, Fritzer N, Staettner S, Tammaa A, Tinelli A, Sparic R, Keckstein J. Uterine sliding sign: a simple sonographic predictor for presence of deep infiltrating endometriosis of the rectum. Ultrasound Obstet Gynecol. 2013 Jun;41(6):692-5. doi: 10.1002/uog.12431.
- Results publication: PubMed 11727863diZerega GS, Campeau JD. Peritoneal repair and post-surgical adhesion formation. Hum Reprod Update. 2001 Nov-Dec;7(6):547-55. doi: 10.1093/humupd/7.6.547.
- Results publication: PubMed 12113430Kavic SM, Kavic SM. Adhesions and adhesiolysis: the role of laparoscopy. JSLS. 2002 Apr-Jun;6(2):99-109.
- Results publication: PubMed 8299773diZerega GS. Contemporary adhesion prevention. Fertil Steril. 1994 Feb;61(2):219-35. doi: 10.1016/s0015-0282(16)56507-8.
- Results publication: PubMed 22054310Mabrouk M, Montanari G, Guerrini M, Villa G, Solfrini S, Vicenzi C, Mignemi G, Zannoni L, Frasca C, Di Donato N, Facchini C, Del Forno S, Geraci E, Ferrini G, Raimondo D, Alvisi S, Seracchioli R. Does laparoscopic management of deep infiltrating endometriosis improve quality of life? A prospective study. Health Qual Life Outcomes. 2011 Nov 6;9:98. doi: 10.1186/1477-7525-9-98.
- Results publication: PubMed 15533368Ouahba J, Madelenat P, Poncelet C. Transient abdominal ovariopexy for adhesion prevention in patients who underwent surgery for severe pelvic endometriosis. Fertil Steril. 2004 Nov;82(5):1407-11. doi: 10.1016/j.fertnstert.2004.03.060.
- Results publication: PubMed 10645861Garry R, Clayton R, Hawe J. The effect of endometriosis and its radical laparoscopic excision on quality of life indicators. BJOG. 2000 Jan;107(1):44-54. doi: 10.1111/j.1471-0528.2000.tb11578.x.
- Results publication: PubMed 9166188Garry R. Laparoscopic excision of endometriosis: the treatment of choice? Br J Obstet Gynaecol. 1997 May;104(5):513-5. doi: 10.1111/j.1471-0528.1997.tb11523.x. No abstract available.
- Results publication: PubMed 17272567Farquhar C. Endometriosis. BMJ. 2007 Feb 3;334(7587):249-53. doi: 10.1136/bmj.39073.736829.BE. No abstract available.
- Individual participant dataSharing planned: Yes. Patients outcomes
Related trials for Endometriosis
Not yet recruiting
Prevalence of Small Intestinal Bacterial Overgrowth (SIBO) in Women With Endometriosis
SIBO, Endometriosis
Recruiting
Endometriosis Transcriptomic Cell Atlas
Endometriosis, Infertility
Not yet recruiting
Psychotherapy in Patients With Endometriosis: Cognitive Behavioral Therapy Versus Acceptance and Commitment Therapy
Endometriosis, Adenomyosis
Not yet recruitingObservational study
Impact of a Diagnosis or Lack of a Diagnosis of Endometriosis Via a Saliva Test on Pain Catastrophizing, Quality of Life, Symptoms of Anxiety and Depression, and Treatment Adherence
Endometriosis
Not yet recruitingPhase 2
PRECISION-E2: Teverelix in Women With Endometriosis - Pharmacodynamics, Safety and Precision Medicine Correlates
Endometriosis Pelvic, Endometriosis Ovaries
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing laparoscopic ovarian suspension in people with Endometriosis and Abdominal Adhesions, run by Carmel Medical Center at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Yuval Kaufman, MD (+97248250336, mdykaufman@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Adhesion formation following laparoscopic surgery with temporary ovarian suspension as assessed in post-operative ultrasound visits at weeks 6,13 following surgery (time frame: From enrollment to last follow-up visit at 13 weeks post surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07087756, which also lists 10 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2025.